Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Revenio Group Oyj is a company focused on providing medical diagnostic solutions, primarily in the fields of ophthalmology. It is known for its innovative products, such as tonometers for eye pressure measurements, which are important in glaucoma examinations. Founded in Finland, the company has its headquarters in Vantaa. Revenio leverages its specialized expertise in medical technology to address specific healthcare needs, with a strategic focus on precision, reliability, and ease of use in its devices. The company's geographic footprint extends across multiple international markets, facilitated by a network of distributors and partners.
View stock
VS
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
View stock

Stock highlights

Stock comparison highlights
Stock name
Revenio Group OyjAbbVie
Last price
€10.59$285.64
Currency
EUR
USD
€445M$504B
21.5080.57
€0.49$3.54
0.880.28
0$6.83
02.43%
Sector
HealthHealth
Employees
76557,000
Ticker
€REG1V$ABBV
Primary listing
XHELNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €REG1V or $ABBV on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.